webinar register page

 Highlighting RenovoRx's RenovoTAMP™ therapy platform with  presenters Dr. Ramtin Agah, RenovoRx’s Chief Medical Officer, Dr. Michael Pishvaian, a Principal Investigator for the Company’s Phase 3 TIGeR-PaC trial, and Shaun Bagai, CEO
Facing Today’s Challenges in Pancreatic Cancer Treatment: Understanding RenovoRx’s Trans-Arterial Micro-Perfusion Therapy Platform
You are invited to our webcast on Thursday, June 21st at 8:00 a.m. ET. Speakers include Dr. Michael Pishvaian, who also serves as Study Chair for the Phase 3 TIGeR-PaC clinical trial, and RenovoRx's CEO, Shaun Bagai. The presentation will address currently available treatment options for pancreatic cancer and why they can fall short of providing an effective solution in fighting this deadly disease, and how the RenovoRx therapy platform re-envisions therapy for this and other difficult-to-treat cancers. Additionally, the presentation will cover the Company’s plan for expanding the utility of its innovative therapy platform and its anticipated milestones for the remainder of the year.The event will include a Q&A session. Learn more about us at https://www.renovorx.com/

Jun 21, 2022 08:00 AM in Eastern Time (US and Canada)

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: .